Olema Pharmaceuticals Stock Price Prediction
| OLMA Stock | USD 24.57 1.53 5.86% |
Momentum 55
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.48) | EPS Estimate Current Year (1.92) | EPS Estimate Next Year (2.31) | Wall Street Target Price 45.9 | EPS Estimate Current Quarter (0.45) |
Using Olema Pharmaceuticals hype-based prediction, you can estimate the value of Olema Pharmaceuticals from the perspective of Olema Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Olema Pharmaceuticals using Olema Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Olema using crowd psychology based on the activity and movement of Olema Pharmaceuticals' stock price.
Olema Pharmaceuticals Short Interest
A significant increase or decrease in Olema Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Olema. Short interest can provide insight into the potential direction of Olema Pharmaceuticals stock and how bullish or bearish investors feel about the market overall.
200 Day MA 11.1532 | Short Percent 0.1231 | Short Ratio 4.95 | Shares Short Prior Month 10.4 M | 50 Day MA 26.094 |
Olema Pharmaceuticals Hype to Price Pattern
Investor biases related to Olema Pharmaceuticals' public news can be used to forecast risks associated with an investment in Olema. The trend in average sentiment can be used to explain how an investor holding Olema can time the market purely based on public headlines and social activities around Olema Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Olema Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Olema Pharmaceuticals.
Olema Pharmaceuticals Implied Volatility | 1.5 |
Olema Pharmaceuticals' implied volatility exposes the market's sentiment of Olema Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Olema Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Olema Pharmaceuticals stock will not fluctuate a lot when Olema Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Olema Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Olema because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Olema Pharmaceuticals after-hype prediction price | USD 24.57 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Olema contract
Based on the Rule 16, the options market is currently suggesting that Olema Pharmaceuticals will have an average daily up or down price movement of about 0.0938% per day over the life of the 2026-04-17 option contract. With Olema Pharmaceuticals trading at USD 24.57, that is roughly USD 0.023 . If you think that the market is fully incorporating Olema Pharmaceuticals' daily price movement you should consider acquiring Olema Pharmaceuticals options at the current volatility level of 1.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Olema Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Olema Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Olema Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Olema Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Olema Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Olema Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Olema Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Olema Pharmaceuticals' historical news coverage. Olema Pharmaceuticals' after-hype downside and upside margins for the prediction period are 6.48 and 42.66, respectively. We have considered Olema Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Olema Pharmaceuticals is relatively risky at this time. Analysis and calculation of next after-hype price of Olema Pharmaceuticals is based on 3 months time horizon.
Olema Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Olema Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Olema Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Olema Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.64 | 18.24 | 0.11 | 0.64 | 11 Events / Month | 6 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
24.57 | 24.57 | 0.00 |
|
Olema Pharmaceuticals Hype Timeline
Olema Pharmaceuticals is now traded for 24.57. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of -0.64. Olema is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is now at 2.64%. %. The volatility of related hype on Olema Pharmaceuticals is about 7506.17%, with the expected price after the next announcement by competition of 23.93. About 90.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.76. Olema Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 11 days. Check out Olema Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Olema Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Olema Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Olema Pharmaceuticals' future price movements. Getting to know how Olema Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Olema Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VTYX | Ventyx Biosciences | (1.59) | 8 per month | 3.82 | 0.17 | 14.25 | (6.90) | 37.04 | |
| CRVS | Corvus Pharmaceuticals | 0.04 | 18 per month | 2.90 | 0.13 | 9.63 | (6.97) | 174.29 | |
| ABSI | Absci Corp | 0.41 | 2 per month | 0.00 | (0.09) | 8.58 | (7.91) | 27.80 | |
| RGNX | Regenxbio | 0.04 | 12 per month | 0.00 | (0.03) | 7.94 | (6.66) | 23.68 | |
| GOSS | Gossamer Bio | (0.07) | 9 per month | 4.27 | 0.07 | 9.59 | (6.57) | 31.39 | |
| PRTA | Prothena plc | (0.04) | 7 per month | 0.00 | (0.04) | 5.10 | (4.36) | 12.28 | |
| VSTM | Verastem | (1.59) | 6 per month | 0.00 | (0.05) | 5.83 | (6.80) | 29.79 | |
| KALV | Kalvista Pharmaceuticals | 0.04 | 15 per month | 3.21 | 0.12 | 8.43 | (5.92) | 25.15 | |
| FDMT | 4D Molecular Therapeutics | 0.37 | 9 per month | 0.00 | (0.03) | 8.07 | (9.30) | 33.45 | |
| LXRX | Lexicon Pharmaceuticals | (0.04) | 15 per month | 4.31 | 0.03 | 9.86 | (7.65) | 26.73 |
Olema Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Olema price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Olema using various technical indicators. When you analyze Olema charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Olema Pharmaceuticals Predictive Indicators
The successful prediction of Olema Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Olema Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Olema Pharmaceuticals based on analysis of Olema Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Olema Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Olema Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Net Debt To EBITDA | 1.12 | 1.06 | Intangibles To Total Assets | 0.001363 | 0.001211 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |